PubMed Health⌕ Search

PubMed · 15244554

Velocity distribution for a two-dimensional sheared granular flow.

Abstract

The velocity distribution for a two-dimensional collection of disks of number density n per unit area and radius a in a channel of width L is studied. The particle-particle collisions are considered to be inelastic with a coefficient of restitution e, while the particle-wall coefficients of restitution are inelastic with a tangential and normal coefficients of restitution, e(t) and e(n), respectively. The Knudsen number, which is the ratio of the channel width and the mean free path of the particles, is varied from Kn<<1 to Kn>>1. In the limit of high Knudsen number, the distribution function for the streamwise velocity is bimodal, as predicted by theory [J. Fluid Mech. 340, 3l9 (1997)]], and the scalings of the moments of the velocity distribution with the Knudsen number are in agreement with the theory. In the low Knudsen number limit, the distribution function for the streamwise velocity is a Gaussian if the coefficient of restitution is close to 1, but assumes the form of a "composite Gaussian" if the coefficient of restitution is not close to 1. The distribution function has a complex structure in the intermediate regime, where there are three maxima in the distribution function near the wall, while the distribution function is bimodal at the center. The granular temperature is accurately predicted by kinetic theory at the center of the channel, but there is dissipation at the wall due to inelastic particle-wall collisions, which results in a significant decrease in the temperature even when the coefficient of restitution is 0.9; this finding is in agreement with previous results with bumpy wall boundary conditions and with specular reflection conditions. The slip velocity at the wall has a power law dependence on the Knudsen number, and the exponent in this power law depends on the coefficients of restitution.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M Bose, V Kumaran. 2004-06-02. Velocity distribution for a two-dimensional sheared granular flow.. https://doi.org/10.1103/physreve.69.061301

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Effectiveness of high-dose versus standard-dose influenza vaccines against hospitalisation according to frailty risk: a prespecified analysis of the randomised trial DANFLU-2.

BACKGROUND: Frailty is a major risk factor for influenza-related complications and can influence vaccine effectiveness. We aimed to assess the relative vaccine effectiveness (rVE) of high-dose (HD-IIV) versus standard-dose inactivated influenza vaccine (SD-IIV) in older adults aged 65 years or older according to frailty risk. METHODS: This study was a prespecified analysis of DANFLU-2, an open-label, individually randomised trial, conducted in Denmark during three consecutive influenza seasons (2022-23, 2023-24, and 2024-25). Adults aged 65 years or older were randomised (1:1) to the HD-IIV or SD-IIV group. The primary endpoint was hospitalisation for influenza or pneumonia. Frailty was defined according to the validated Hospital Frailty Risk Score (HFRS) based on ICD-10 codes within 10 years before randomisation. Participants were stratified into three HFRS categories, namely low (<5 points), intermediate (5-15 points), and high (>15 points) frailty risk. The rVE of HD-IIV versus SD-IIV against the primary endpoint was assessed across prespecified HFRS categories and treating HFRS as a continuous variable. Pearson's chi-square test was used to compare safety events across frailty risk groups and randomisation groups. FINDINGS: Among 332&#x2009;438 randomised participants (mean age 73&#xb7;7 years [SD 5&#xb7;8]; 161&#x2009;538 [48&#xb7;6%] were female), 276&#x2009;173 (83&#xb7;1%) had low frailty risk, 52&#x2009;395 (15&#xb7;8%) had intermediate frailty risk, and 3861 (1&#xb7;2%) had high frailty risk. The primary endpoint of hospitalisation for influenza or pneumonia occurred in 1424 (0&#xb7;5%) of 276&#x2009;173 participants with low frailty risk, 761 (1&#xb7;5%) of 52&#x2009;395 with intermediate frailty risk, and 163 (4&#xb7;2%) of 3861 with high frailty risk (relative risk [RR] for intermediate vs low frailty risk 2&#xb7;8 [95% CI 2&#xb7;6-3&#xb7;1]; RR for high vs low frailty risk 8&#xb7;2 [7&#xb7;0-9&#xb7;6]). HFRS as a continuous variable significantly modified the effect of HD-IIV versus SD-IIV against the primary endpoint with higher rVE estimates with increasing HFRS (pinteraction=0&#xb7;020). The rVE was 0&#xb7;2% (95% CI -10&#xb7;8 to 10&#xb7;2) among those with low frailty risk, 13&#xb7;1% (-0&#xb7;4 to 24&#xb7;8) among those with intermediate frailty risk, and 19&#xb7;9% (-10&#xb7;3 to 42&#xb7;1) among those with high frailty risk. No significant interaction was observed when HFRS was assessed according to the prespecified categorical frailty groups (pinteraction=0&#xb7;17). The proportion of participants with at least one serious adverse event increased across frailty risk groups (13&#x2009;366 [4&#xb7;8%] of 275&#x2009;795 for low frailty risk, 5475 [10&#xb7;5%] of 52&#x2009;315 for intermediate frailty risk, and 777 [20&#xb7;2%] of 3850 for high frailty risk; p<0&#xb7;0001), with similar proportions of serious adverse events in the HD-IIV and SD-IIV groups for each frailty risk group. INTERPRETATION: Among adults aged 65 years or older in Denmark, frailty risk might modify the effects of HD-IIV versus SD-IIV against hospitalisation for influenza or pneumonia, with higher rVE estimates with increasing frailty risk. These findings might support considering high-dose influenza vaccines for frail older adults. However, effect modification was not evident when frailty was assessed using prespecified categorical subgroups, and subgroup-specific estimates were imprecise, with 95% CIs crossing the null. These results should be considered exploratory, warranting further investigation. FUNDING: The DANFLU-2 trial was funded by Sanofi.

Journal Article↗